Genflow Biosciences to present GF-1004 canine ageing trial results in Toronto

Sep 29, 2026 03:42 (26d ago)

Verifying

Genflow Biosciences will present full results from its canine ageing trial.
GF-1004 targets slowing ageing and will be assessed for safety and potential health benefits.
The results will be presented at the Animal Longevity Summit in Toronto.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.